11-28-2017 New article. SHIKARI® Q-CETUX ELISA kit have been used to measure cetuximab levels in a comparative study with a new method utilizing LC-MS/MS method and validated accordingly
11-24-2017 New SHIKARI® ELISA kits for total anti-drug antibodies to Infliximab, Infliximab-biosimilar, CT-P13 and Adalimumab will be launched very soon! Click to see details
11-21-2017 New publication Johannes Gojo, Robert Sauermann, Ursula Knaack, Irene Slave, Andreas Peyrl, Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies. Drugs R D 17:469-474, 2017
09-09-2017 Our new Distributiors; IWAI JAPAN and USA, BioChemMack JCS Russia..
07-27-2017 5 New Publications are added; 2 patents, 2 peer reviewed articles and 1 PhD thesis..
02-20-2017 new publication “H. Akbulut, et al: The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC). 1553 P, Annals of Oncology, Volume 27, 2016.
02-20-2017 New kit for quantitative measurement of anti-bevacizumab antibodies with confirmation reagentdone by using SHIKARI® ELISA kits.
02-06-2017 Two new kits for quantitative measurement of rituximab and anti-rituximab antibodies with confirmation reagent.